HOME PAGE
Save 50% with Home Delivery

SeniorHealthWeek
Alzheimer's
Arthritis
Bladder Control
Breast Cancer
Cholesterol
Colorectal Cancer
Depression
Diabetes
Eye Disease
GERD & Heartburn
Heart Disease
Hypertension
Joint Replacement
Lung Cancer
Menopause
Osteoporosis
Parkinsons
Prostate Cancer
Skin Cancer
Senior Health Report: Heart Disease
Health News You Can Use •

Heart Disease News:

Red Wine Can Reduce Heart Disease Risk in Obese People

Obese people can reduce their risk of heart disease by consuming light to moderate amounts of alcohol in general and red wine in particular, according to a study reported in the July issue of the European Journal of Clinical Nutrition.

Australian researchers found that obese people who drank alcohol in these amounts had lower concentrations of homocysteine, a blood protein that at high levels can increase one's risk of developing heart disease.

"The advantages of light to moderate alcohol consumption in reducing cardiovascular risk are very powerful," study author Dr. John Dixon, of Alfred Hospital in Melbourne, told Medical Week. "It is important to realize that the dose required for benefit is very low two to 10 standard drinks a week. A glass of red wine most days would be sufficient to obtain all the benefits."

Dixon and his colleagues at the hospital obtained self-reported alcohol histories from 350 obese men and women as part of an assessment they underwent before having their obesity treated surgically.

After gathering information about the amount, frequency, timing and type of alcohol that the participants consumed, the researchers measured their subjects' homocysteine levels.

The researchers found that study participants who consumed up to 100 grams of any type of alcohol a week had serum homocysteine concentrations that were 11 percent lower than those who never or rarely drank alcohol.

Red wine by itself turned out to be an independent predictor for lower homocysteine concentrations, according to the researchers. Study participants who drank up to 100 grams of red wine had serum concentrations of homocysteine that were 17 percent lower than non-alcohol consumers, 13 percent lower than beer and spirit consumers and 11 percent lower than white wine drinkers.

Although the researchers are not sure why homocysteine concentrations are lower in red wine consumers, Dixon explained that it is likely related to the non-alcohol components of red wine such as the polyphenols reducing oxidation and metabolic demand. He added that this area needs more research.

Dixon said high-risk patients such as those with Type 2 diabetes or with a family history of coronary artery disease should consider using red wine as a therapeutic agent.

"If the benefits of red wine came in a tablet it would be one of the most prescribed medications," Dixon observed.

However, Dixon said any suggestions that alcohol consumption is beneficial must be taken with caution. "As with other therapeutic agents there are precautions and contraindications," he said. "A past history of alcoholism or other addictive substance abuse or taking a medication that interacted with alcohol would be a contraindication. Those with a family history of alcoholism may be seen as a relative contraindication."

Source: Heart Disease Week of August 4, 2002

 

About This Site
Privacy Policy
Advertising Policy
Contact Us

USE OF THIS SITE SIGNIFIES ACCEPTANCE OF THIS USER AGREEMENT: The information provided in this and our other sites is for educational purposes only, and it is not intended nor implied to be a substitute for professional medical advice. Always consult your own physician or healthcare provider with any questions you may have regarding a medical condition. Hypertext links to other sites are for the convenience of our Web site viewers and do not constitute any endorsement. We are not responsible for the content of linked sites in any way. This site is intended for personal use only and may not be used for any commercial purpose.